Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Division of Analgesic, Anti-Inflammatory Drugs seeking permanent director; Chambers is interim head.

Executive Summary

FDA ANALGESIC, ANTI-INFLAMMATORY DRUGS DIVISION ACTING DIRECTOR CHAMBERS is overseeing the division while FDA completes a search for a rheumatologist or analgesiologist to take on the permanent division director post. Wiley Chambers, MD, most recently served as a medical officer for ophthalmic drugs in the then-Division of Dermatologic & Ophthalmic Drugs. In 1991-1992, he was acting director of the Division of Imaging, Surgical & Dental Diagnostic Products.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS027577

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel